Zurich Cantonal Bank’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $494K | Hold |
13,657
| – | – | ﹤0.01% | 1943 |
|
|
2026
Q1 | $452K | Buy |
+13,657
| New | +$578K | ﹤0.01% | 1888 |
|
|
2025
Q4 | – | Sell |
-11,470
| Closed | -$480K | – | 2777 |
|
|
2025
Q3 | $401K | Buy |
11,470
+686
| +6% | +$23.8K | ﹤0.01% | 1858 |
|
|
2025
Q2 | $319K | Buy |
10,784
+60
| +0.6% | +$1.71K | ﹤0.01% | 1924 |
|
|
2025
Q1 | $320K | Sell |
10,724
-432
| -4% | -$13.2K | ﹤0.01% | 1857 |
|
|
2024
Q4 | $320K | Buy |
11,156
+1,422
| +15% | +$47.1K | ﹤0.01% | 1907 |
|
|
2024
Q3 | $376K | Sell |
9,734
-11
| -0.1% | -$392 | ﹤0.01% | 1731 |
|
|
2024
Q2 | $314K | Buy |
9,745
+959
| +11% | +$33.3K | ﹤0.01% | 1803 |
|
|
2024
Q1 | $341K | Sell |
8,786
-55
| -0.6% | -$1.92K | ﹤0.01% | 1724 |
|
|
2023
Q4 | $272K | Buy |
8,841
+1,967
| +29% | +$49.3K | ﹤0.01% | 1899 |
|
|
2023
Q3 | $154K | Sell |
6,874
-218
| -3% | -$4.97K | ﹤0.01% | 2134 |
|
|
2023
Q2 | $152K | Sell |
7,092
-215
| -3% | -$4.88K | ﹤0.01% | 2102 |
|
|
2023
Q1 | $175K | Buy |
7,307
+1,097
| +18% | +$29.1K | ﹤0.01% | 1957 |
|
|
2022
Q4 | $144K | Buy |
6,210
+1,627
| +36% | +$32.8K | ﹤0.01% | 2033 |
|
|
2022
Q3 | $73K | Hold |
4,583
| – | – | ﹤0.01% | 2429 |
|
|
2022
Q2 | $81K | Hold |
4,583
| – | – | ﹤0.01% | 2376 |
|
|
2022
Q1 | $93K | Hold |
4,583
| – | – | ﹤0.01% | 2317 |
|
|
2021
Q4 | $86K | Hold |
4,583
| – | – | ﹤0.01% | 2573 |
|
|
2021
Q3 | $90K | Hold |
4,583
| – | – | ﹤0.01% | 2394 |
|
|
2021
Q2 | $108K | Hold |
4,583
| – | – | ﹤0.01% | 2181 |
|
|
2021
Q1 | $109K | Hold |
4,583
| – | – | ﹤0.01% | 2111 |
|
|
2020
Q4 | $92K | Hold |
4,583
| – | – | ﹤0.01% | 2244 |
|
|
2020
Q3 | $95K | Hold |
4,583
| – | – | ﹤0.01% | 2011 |
|
|
2020
Q2 | $80K | Buy |
4,583
+2,517
| +122% | +$49.3K | ﹤0.01% | 2043 |
|
|
2020
Q1 | $34K | Buy |
2,066
+1,152
| +126% | +$23.8K | ﹤0.01% | 2121 |
|
|
2019
Q4 | $19K | Hold |
914
| – | – | ﹤0.01% | 2510 |
|
|
2019
Q3 | $10K | Hold |
914
| – | – | ﹤0.01% | 2551 |
|
|
2019
Q2 | $12K | Hold |
914
| – | – | ﹤0.01% | 2551 |
|
|
2019
Q1 | $14K | Sell |
914
-1,043
| -53% | -$16.7K | ﹤0.01% | 2481 |
|
|
2018
Q4 | $34K | Hold |
1,957
| – | – | ﹤0.01% | 2237 |
|
|
2018
Q3 | $29K | Hold |
1,957
| – | – | ﹤0.01% | 2381 |
|
|
2018
Q2 | $47K | Sell |
1,957
-1,097
| -36% | -$27K | ﹤0.01% | 2168 |
|
|
2018
Q1 | $78K | Hold |
3,054
| – | – | ﹤0.01% | 1754 |
|
|
2017
Q4 | $56K | Buy |
+3,054
| New | +$43.7K | ﹤0.01% | 1978 |
|
Other funds holding COLL
JT
EAM
Zurich Cantonal Bank's COLL Position: Q2 2026 in Review
Zurich Cantonal Bank held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 13,657 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.
Zurich Cantonal Bank first reported a position in COLL in Q4 2017 and has held it in 34 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- Zurich Cantonal Bank held 13,657 shares of Collegium Pharmaceutical worth $494K as of Q2 2026.
- Zurich Cantonal Bank left its Collegium Pharmaceutical share count unchanged in Q2 2026.
- Collegium Pharmaceutical made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1943 holding.
- Zurich Cantonal Bank first reported a position in Collegium Pharmaceutical in Q4 2017 and has held it in 34 quarters since.
- 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.